Johnson & Johnson said to have approached Abiomed
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
235,750$
-38,13%
Echtzeit-Aktienkurs ABIOMED
Bid:
Ask:
Nachrichten zur ABIOMED Aktie
Abiomed (ABMD) Beats Q2 Earnings Estimates
Abiomed (ABMD) delivered earnings and revenue surprises of 23.81% and 2.70%, respectively, for the quarter ended September 2022. Do the…
J&J to buy heart medical tech firm Abiomed for $17.3bn
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
J&J to Buy Heart Medical Tech Firm Abiomed for $17.3 Billion
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Abiomed Stock Soars After $16.6 Billion Johnson & Johnson Takeover Amid Deeper Medical Devices Push
Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…
Abiomed Stock Surges on Johnson & Johnson Takeover
The pharmaceutical giant will buy the heart-pump maker for $380 a share....…
WDH: Johnson & Johnson will Herzpumpenhersteller Abiomed kaufen
(Im ersten Satz wurde ein überflüssiger Wortteil gestrichen.)NEW BRUNSWICK (dpa-AFX) - Der Gesundheitskonzern Johnson & Johnson (JohnsonJohnson) will mit einem…
Abiomed To Be Bought By Johnson & Johnson In $16.6 Bln Deal; Stock Surges In Pre-market
NEW BRUNSWICK (dpa-AFX) - Drug major Johnson & Johnson (JNJ) Tuesday said it has entered into a definitive agreement to…
Abiomed Inc. Q2 Profit Increases, beats estimates
WASHINGTON (dpa-AFX) - Abiomed Inc. (ABMD) reported earnings for its second quarter that increased from last year and beat the…
Johnson & Johnson will Herzpumpenhersteller Abiomed kaufen
NEW BRUNSWICK (dpa-AFX) - Der Gesundheitskonzern Johnson & Johnson (JohnsonJohnson) will mit einem Milliardenzukauf sein Geschäft mit Medizintechnikgeschäft stärken. Das…
J&J to buy cardio technology company Abiomed for $16.6B
Johnson & Johnson is spending about $16.6 billion to buy cardiovascular technology company Abiomed and build up its medical device…
Stocks making the biggest moves in the premarket: Abiomed, Uber, SoFi, Pfizer and more
The stocks making the biggest moves in premarket trading include Abiomed, Uber, SoFi, Pfizer, and more....…
Form 8-K ABIOMED INC For: Oct 31
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Abiomed reports mixed FQ2 earnings
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
J&J to buy cardiovascular technology Abiomed in $16.6B deal
Johnson & Johnson is spending about $16.6 billion to buy cardiovascular technology company Abiomed and build up its medical device…
Johnson & Johnson to buy medtech company Abiomed for $380 per share in cash
Johnson & Johnson is set to buy medical device company Abiomed in cash for $380 per share. CNBC's 'Squawk Box'…
Johnson & Johnson expands MedTech footprint with acquisition of Abiomed
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
UPDATE 1-J&J to buy Abiomed in $16.6 bln deal
...(Adds deal details)
Nov 1 (Reuters) - Johnson & Johnson said......…
J&J to buy Abiomed in $16.6 billion deal
...(Reuters) - Johnson & Johnson said on Tuesday it will acquire......…
Abiomed stock rockets after J&J buyout deal valued at $16.6 billion
Shares of Abiomed Inc. rocketed 48.8% toward a 14-month high in premarket trading Tuesday, after the provider of medical…
Johnson & Johnson will buy cardiovascular technology company Abiomed in $16.6 billion deal
Johnson & Johnson will buy cardiovascular technology company Abiomed in $16.6 billion deal...…
Johnson & Johnson to Acquire Abiomed
NEW BRUNSWICK, N.J. & DANVERS, Mass.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ), the worlds largest, most diversified healthcare products company, and…
J&J to buy Abiomed in $16.6 bln deal
...Nov 1 (Reuters) - Jonhson & Johnson said on
Tuesday it will acquire......…
Is Abiomed (ABMD) a Solid Growth Stock? 3 Reasons to Think "Yes"
Abiomed (ABMD) possesses solid growth attributes, which could help it handily outperform the market....…
The Zacks Analyst Blog Highlights Nevro, Masimo, Abiomed and Glaukos
Nevro, Masimo, Abiomed and Glaukos are part of the Zacks top Analyst Blog....…
Implied Volatility Surging for Abiomed (ABMD) Stock Options
Investors need to pay close attention to Abiomed (ABMD) stock based on the movements in the options market lately....…
Abiomed schließt alle nach der Zulassung durchgeführten Impella-Studien in den Bereichen Hochrisiko-PCI, kardiogener Schock, kardiogener Schock nach Kardiotomie und Rechtsherzinsuffizienz erfolgreich ab
DANVERS, Mass.--(BUSINESS WIRE)--Abiomed (Nasdaq: ABMD) teilt mit, dass die US-amerikanische Aufsichtsbehörde für Lebensmittel und Arzneimittel (FDA) die nach der Zulassung…
Why Abiomed (ABMD) Could Beat Earnings Estimates Again
Abiomed (ABMD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…
Abiomed completes post-approval reports for FDA for Impella heart pumps
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Abiomed started at buy with $300 stock price target at Mizuho
Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…
Abiomed (ABMD) is an Incredible Growth Stock: 3 Reasons Why
Abiomed (ABMD) possesses solid growth attributes, which could help it handily outperform the market....…